The CCR2-V64I polymorphism has been extensively studied and several reports show an association of the CCR2-64I variant with reduced risk of progression to AIDS in HIV-infected individuals, [20-23], multiple sclerosis [24] and development of breast cancer [25]. This evidence concerns the gene CCR2 and multiple sclerosis.